Press release
Peanut Allergy Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 | DBV Technologies, Regeneron Pharmaceuticals, Cour Pharmaceutical, HAL Allergy, and others.
Peanut Allergy Pipeline
Key Takeaways from the Peanut Allergy Pipeline Report
• DelveInsight's Peanut Allergy Pipeline report depicts a robust space with 15+ active players working to develop 15+ pipeline therapies for Peanut Allergy treatment.
• The leading companies working in the Peanut Allergy Market include DBV Technologies, Regeneron Pharmaceuticals, Cour Pharmaceutical, HAL Allergy, InnoUp Farma S.L., Vedanta Biosciences, Astellas Pharma, Intrommune Therapeutics, Genentech, ASIT biotech, BlueWillow Biologics, Allergy Therapeutics, Alladapt Immunotherapeutics, Desentum, Camallergy, Prota Therapeutics, IgGenix, and others.
• Promising Peanut Allergy Pipeline Therapies in the various stages of development include Dupilumab, AR101, CNP-201, Etokimab, HAL-MPE1, ASP0892, INT301, and others.
• October 2023: ALK-Abello A/S announced a study of Phase 1 clinical trials for Peanut SLIT-tablet. This clinical research study investigates the safety and tolerability of a peanut SLIT-tablet. This is a phase I, open-label, dose-escalation, multi-site trial including subjects with peanut allergy confirmed by screening double-blind, placebo-controlled food challenge. The trial is conducted in 2 parts; part 1 will determine the entry dose of the up-dosing regimen (UDR) in adults and adolescents and part 2 will characterize the tolerability of the up-dosing regimen in adults, adolescents and children.
• Novemeber 2023: Novartis Pharmaceuticals announced a study of Phase 3 clinical trials for ligelizumab. This is a 52-week, Phase 3 multi-center, randomized, double-blind and placebo-controlled study to assess the safety and clinical efficacy of two dosing regimens of ligelizumab (240 mg and 120 mg) subcutaneous injection every 4 weeks (SCq4w) in participants with a medically confirmed diagnosis of IgE-mediated peanut allergy.
Request a sample and discover the recent advances in Peanut Allergy Treatment Drugs @ Peanut Allergy Pipeline Report- https://www.delveinsight.com/report-store/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the Peanut Allergy pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Peanut Allergy NDA approvals (if any), and product development activities comprising the technology, Peanut Allergy collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Peanut Allergy Overview
A peanut allergy is a reaction that occurs when your body mistakenly identifies peanuts as harmful substances. When you eat peanuts or food containing peanuts, your immune system -the body's natural defense system that fights infections and diseases-overreacts and can cause a serious, even life-threatening response.
Find out more about Peanut Allergy Therapeutics Assessment @ Peanut Allergy Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Peanut Allergy Emerging Drugs Profile
• Viaskin Peanut: DBV Technologies
• Dupilumab: Regeneron Pharmaceuticals/Sanofi
• CNP-201: Cour Pharmaceutical
Peanut Allergy Pipeline Therapeutics Assessment
There are approx. 15+ key companies which are developing the Peanut Allergy therapies. The Peanut Allergy companies which have their Peanut Allergy drug candidates in the most advanced stage, i.e. preregistration include, DBV Technologies.
DelveInsight's Peanut Allergy Pipeline report covers around 15+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Peanut Allergy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intradermal
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type
Peanut Allergy Pipeline Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Learn more about the emerging Peanut Allergy Pipeline Therapies @ Peanut Allergy Clinical Trials Assessment- https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Peanut Allergy Pipeline Report
• Coverage- Global
• Peanut Allergy Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Peanut Allergy Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Peanut Allergy Companies- DBV Technologies, Regeneron Pharmaceuticals, Cour Pharmaceutical, HAL Allergy, InnoUp Farma S.L., Vedanta Biosciences, Astellas Pharma, Intrommune Therapeutics, Genentech, ASIT biotech, BlueWillow Biologics, Allergy Therapeutics, Alladapt Immunotherapeutics, Desentum, Camallergy, Prota Therapeutics, IgGenix, and others.
• Peanut Allergy Pipeline Therapies- Dupilumab, AR101, CNP-201, Etokimab, HAL-MPE1, ASP0892, INT301, and others.
Dive deep into rich insights for new drugs for Peanut Allergy Treatment, Visit @ Peanut Allergy Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Peanut Allergy: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Preregistration)
7. Viaskin Peanut: DBV Technologies
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. Dupilumab: Regeneron Pharmaceuticals
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I/II)
13. CNP-201: Cour Pharmaceutical
14. Drug profiles in the detailed report…..
15. Preclinical and Discovery Stage Products
16. Peanut-NE01 vaccine: BlueWillow Biologics
17. Drug profiles in the detailed report…..
18. Inactive Products
19. Peanut Allergy Key Companies
20. Peanut Allergy Key Products
21. Peanut Allergy- Unmet Needs
22. Peanut Allergy- Market Drivers and Barriers
23. Peanut Allergy- Future Perspectives and Conclusion
24. Peanut Allergy Analyst Views
25. Peanut Allergy Key Companies
26. Appendix
For further information on the Peanut Allergy Pipeline therapeutics, reach out to Peanut Allergy Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Important Published Links
https://logcworld.mn.co/posts/46134506
https://marketingops.mn.co/posts/46134636
https://motorcycle-events.mn.co/posts/46134899
https://intuitive-schooling.mn.co/posts/46135011
https://plenty-of-heathens.mn.co/posts/advancements-and-market-trends-in-langerhans-cell-histiocytosis-treatment
https://shopsanity.mn.co/posts/understanding-the-langerhans-cell-histiocytosis-market-current-landscape-and-future-prospects
https://mccoterie.mn.co/posts/46135751
https://go02100.mn.co/posts/46136119
https://freesaloneducation.mn.co/posts/46136215
https://sokomtaani.mn.co/posts/46136615
https://skillcrush.mn.co/posts/46136691
https://advicehonest.mn.co/posts/46136795
https://evening-newss.mn.co/members/20271728
https://omind.mn.co/members/20271735
https://shop1606.mn.co/posts/45816438
https://council-of-light.mn.co/posts/45816468
https://chanspirations.mn.co/posts/45816726
https://hulu-com-forgot.mn.co/posts/45816832
https://bucketseems-news.mn.co/members/20271966
https://sentinels.mn.co/members/20272156
https://akademe.mn.co/posts/navigating-the-acne-vulgaris-market-trends-treatments-and-technological-advances
https://tc-2345.mn.co/posts/45818004
https://gene-keys-genealogy.mn.co/posts/45818150
https://take-your-phone.mn.co/posts/45818381
https://digitaldrip.mn.co/posts/45818561
https://network-24921.mn.co/posts/45818644
https://friends-of-zizira.mn.co/members/20272206
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653
https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.uplabs.com/dennydones9
https://www.zazzle.com/mbr/238605385879691977
https://independent.academia.edu/HavenSmith2
https://play.eslgaming.com/player/19736877/
https://creators.audiomack.com/dennydones1
https://piano.masto.host/@dennydones9
https://tech4goodwales.mn.co/posts/the-evolving-landscape-of-the-major-depressive-disorder-market
https://worldletinews.mn.co/members/20156129
https://community.greeka.com/users/dennydones9
https://www.exchangle.com/dennydones9
https://old.meneame.net/user/dennydones9
https://gsap.com/community/profile/159086-denny-dones/
https://www.pling.com/u/dennydones9/
https://shaunbook.mn.co/posts/type-1-diabetes-market-size-forecast-and-outlook-2032
https://zip-launchpad.mn.co/posts/45579349
https://dj-club-sf.mn.co/posts/45579415
https://wwwpreparatorianis.mn.co/posts/45579543
https://www.projectnoah.org/users/dennydones9
https://naijases.mn.co/posts/type-1-diabetes-market-future-trends-and-opportunities
https://indicate.mn.co/posts/45580238
https://linkasia.mn.co/posts/45580415
https://playhq.mn.co/posts/45580609
https://coco-quinn.mn.co/posts/45580757
https://aeros.mn.co/posts/45751762
https://churecipe.mn.co/posts/45751826
https://itravel.mn.co/members/20248979
https://hubvin.mn.co/posts/45752020
https://drujrake.mn.co/posts/45752126
https://together.mn.co/posts/45752522
https://bipolarjungle.mn.co/posts/45752571
https://mossfon.mn.co/posts/45752666
https://create-lifestyle.mn.co/posts/45753329
https://gelardas.mn.co/members/20249381
https://bloby.mn.co/posts/45753578
https://cic-mun.mn.co/posts/45753710
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peanut Allergy Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 | DBV Technologies, Regeneron Pharmaceuticals, Cour Pharmaceutical, HAL Allergy, and others. here
News-ID: 3314089 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Peanut
Peanut Butter Market 2020-2027 Advance Study Focusing On Major Product Types- S …
Peanut Butter Market Overview 2020-2027:
Peanut butter market is anticipated to dominate the market with a market value of USD 4.20 billion in 2019 and is expected to grow with a growth rate of 6.10% in the forecast period of 2020 to 2027. The latest Market report by a Data Bridge Market Research with the title [Global Peanut Butter Market – Industry Trends and Forecast to 2027].
Get a PDF Sample copy (including COVID-19 impact analysis and up-to 30% discount ) @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-peanut-butter-market
In…
Peanut Butter Manufacturing Unit
Peanut butter is a high calorie, high protein product manufactured by grinding peanuts. It is a good alternative for dairy butter and widely used as a bread spread. Peanut butter is popular amongst Americans, and it is a part of their daily breakfast.
The demand for peanut butter is susceptible to consumer spending. As disposable income increases, the willingness of the people to purchase the peanut butter also increases. On…
Peanut Sauce Market 2019 | Worldwide Forecast 2025 | Major Players – Jif, PBfi …
Peanut Sauce Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/85716
UpMarketResearch offers a latest published report on “Global Peanut Sauce Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage…
Drinkable Peanut Powder Market | Top Key Players are Golden Peanut and Tree Nuts …
Peanuts are a high-protein, nutritious food that are ready-to-eat with little preparation or can be eaten raw. Peanut can be processed by roasting and ground into various food products. Peanut shakes and smoothies segments are gaining significant traction in the global drinkable peanut powder market.
Rising demand for the healthy beverages such as drinkable peanut powder products driving the market. In addition, food manufacturers are developing peanut powder which is based…
Hormel Foods, J.M. Smucker Company, Saratoga Peanut Butter Company, Peanut Butte …
The market for Peanut Paste is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Peanut Paste Market Insights, Forecast to 2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an…
Peanut Butter Market Report 2018: Segmentation by Product (Regular Peanut Butter …
Global Peanut Butter market research report provides company profile for Hormel Foods Corporation, Boulder Brands, Kraft Canada, Algood Food Company, Procter & Gamble, Unilever, The J.M. Smucker Company and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018…
